Check out this morning’s top movers from around Wall Street, compiled by The Fly.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
HIGHER –
- Intra-Cellular (ITCI) up 34% after Johnson & Johnson (JNJ) and the company announced that they have entered into a definitive agreement under which Johnson & Johnson will acquire all outstanding shares of Intra-Cellular Therapies for $132.00 per share
- Sage Therapeutics (SAGE) up 36% after confirming that Biogen (BIIB) has submitted to the company an unsolicited, nonbinding proposal to acquire all of the outstanding shares of Sage Therapeutics not already owned by Biogen for $7.22 per share
UP AFTER PRELIMINARY EARNINGS –
DOWN AFTER PRELIMINARY EARNINGS –
LOWER –
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ITCI:
- Johnson & Johnson to Acquire Intra-Cellular Therapies
- M&A News: Intra-Cellular Stock Rallies 36% on News of $14.6B Acquisition by Johnson & Johnson
- Johnson & Johnson to acquire Intra-Cellular for $132.00 per share in cash
- Johnson & Johnson exploring bid for Intra-Cellular Therapies, Bloomberg reports
- Intra-Cellular price target raised to $118 from $100 at BofA